<p>The European Commission's initial investigation period will expire on October 25, 2007, unless extended. US antitrust clearance was already granted on September 17, 2007. Siemens expects to receive
To date, 22 patients have been treated with 15 having completed the study. Five patients withdrew from the study, and two patients are still on study. A total
The marketing authorization application seeks approval for oral alitretinoin in the treatment of severe refractory chronic hand eczema (CHE) and is based on a clinical program comprising almost
This study will treat 25 patients affected by a specific cystic fibrosis (CF) mutation (delF508). As a primary endpoint the study will investigate the effect of miglustat on
The 10-year partnership, known as the Novartis-Massachusetts Institute of Technology (MIT) Center for Continuous Manufacturing, will work to develop new technologies that could replace the conventional batch-based system
Under the terms of the new agreement, Beijing Med-Pharm will acquire the remaining of the issued share capital of Hong Kong Fly International Health Care Limited, a Hong
Diffusion said that the drug uses a novel mechanism of action allowing more oxygen to reach oxygen-deprived tissues in the body. The company’s next clinical study will examine
The trial is designed to study the effect of Hyphanox 200mg tablets taken once a day orally for three months. Efficacy is defined as both complete clinical and
Under terms of the agreement, effective January 1, 2008, Ascend Therapeutics will be responsible for marketing and sales of Prochieve 4% in the US using its existing 100-person
In this role Mr Lowth will be responsible for finance and information services. Mr Lowth joins AstraZeneca from Scottish Power where he was finance director following two years
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.